Johnson & Johnson services, Inc., Novartis AG and F. Hoffmann-La Roche Ltd are Dominating The Global Drug Delivery Market in 2019

Global Drug Delivery Market is expected to grow with the CAGR of 8.0% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report at https://www.databridgemarketresearch.com/reports/global-drug-delivery-market

Global drug delivery market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in global drug delivery market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, In January 2020, Janssen Pharmaceutical Companies of Johnson & Johnson stated that EC has given the grant to market Erleada in combination with androgen deprivation therapy (ADT), which is used to treat metastatic hormone-sensitive prostate cancer (mHSPC).

Johnson & Johnson Services, Inc. is the dominating player in global drug delivery market. The other key players existing in the market includes Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, Antares Pharma, GlaxoSmithKline Plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Nemera and Sanofi among others.

Drug Delivery Market

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. headquartered in New Jersey, U.S. was founded in 1886. The company is engaged in the research and development, manufacturing and sale of a wide range of products in the health care field. The company has multiple business segments such as pharmaceutical, medical devices, consumer, in which pharmaceutical and consumer is the market focused segment. They provide a wide range of products in categories such as immunology, cardiovascular & metabolic disease, pulmonary hypertension, infectious diseases & vaccines, neuroscience and oncology. The market focused categories are immunology, cardiovascular & metabolic disease, infectious diseases & vaccines, neuroscience and oncology.   

  • In December 2019, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. said that the company got EC approval for SPRAVATO nasal spray, which will enhance their already wide product portfolio.

The company has wide global presence across the globe such as Europe, Asia-Pacific, North America, South America, Middle East and Africa. In addition to it, the company also generates its revenue from the various subsidiary companies such as Johnson & Johnson Vision Care, Inc. (U.S.), Neutrogena (U.S.), DePuy Synthes (U.S.), Ethicon USA, LLC. (U.S.), Janssen Global Services, LLC (Belgium) among others.

Novartis AG

The company is headquartered in Basel, Switzerland and established in 1996. The company is focusing on providing innovation in medicines in order to fulfil all healthcare needs. The company has multiple business segments such as innovative medicines and Sandoz. The company offers consumers, patients, healthcare professionals and patient support programs. The product categories include disease areas and platform & technology in which the market focused category is disease areas.

  • In January 2020, Novartis AG stated the EU approval of Mayzent which is used to treat patients with secondary progressive multiple sclerosis and also it is the first oral treatment for multiple sclerosis.

The company has wide geographical presence in Asia-Pacific, Europe, Middle East, North America and Latin America. In addition to it, the company also generates its revenue from the various subsidiary companies such as Sandoz International GmbH (Germany), AveXis, Inc. (U.S.), Hexal AG (Germany), Novartis India Ltd. (India), Novartis Pharmaceuticals UK Limited (U.K.) among others.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche Ltd is headquartered in Basel, Switzerland which was founded in 1896. The company focuses on the development, sales and manufacturing of pharmaceuticals and diagnostics products. The company offers wide range of product categories such as pharmaceuticals, solutions for diagnostics and products for researchers in which market focused categories includes pharmaceuticals and solutions for diagnostics.

  • In September 2019, F. Hoffmann-La Roche Ltd’s new Tecentriq-based combination therapy was used as an initial treatment for most conventional form of advanced lung cancer.  

The company has wide global presence in Asia-Pacific, North America, Europe, Oceania and Africa.  


Browse Related Reports

Global Pulmonary Drug Delivery Market - Industry Trends and Forecast to 2027

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary/Respiratory Drug Delivery Market – Industry Trends and Forecast to 2027

Global Nasal Drug Delivery Market – Industry Trends and Forecast to 2027

Global Inflammatory Disease Drug Delivery Market – Industry Trends & Forecast to 2026

Asia-Pacific Drug Delivery Market – Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Industry Trends and Forecast to 2027

Middle East and Africa Drug Delivery Market – Industry Trends and Forecast to 2027

Global Liposome Drug Delivery Market - Industry Trends and Forecast to 2027

Global Buccal Drug Delivery Market - Industry Trends and Forecast to 2026

U.S. Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Drug Delivery Market – Industry Trends and Forecast to 2027

Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Asia-Pacific Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Europe Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Middle East - Africa Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

North America Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Drug Delivery Market – Industry Trends and Forecast to 2027

Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

North America Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Topical Drug Delivery Market – Industry Trends and Forecast to 2027

North America Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Needle-Free Drug Delivery Market – Industry Trends - Forecast to 2026

Global Implantable Drug Delivery Market- Industry Trends and Forecast to 2025